¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"therapeutic group"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • functional group
    ÀÛ¿ë±â
  • glucophore group
    ´Ü¸À´Ü
  • group
    1. ±º, ¹«¸®, Áý´Ü 2. ±â 3. Á· 4. ±×·ì
  • group antigen
    ¹«¸®Ç׿ø, ±ºÇ׿ø
  • group audiometry
    Áý´Üû·Â°Ë»ç
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢
  • group dynamics
    Áý´Ü¿ªÇÐ, Áý´Ü¿ªµ¿
  • group fascicular repair
    ½Å°æ¼¶À¯´Ù¹ß±ººÀÇÕ(¼ú)
  • group medicine
    Áý´ÜÁø·á, Çùµ¿Áø·á
  • group practice
    Áý´Ü°³¿ø, Áý´Ü°³¾÷
  • group psychotherapy
    Áý´ÜÁ¤½Å¿ä¹ý
  • group reference value
    Áý´ÜÂü°íÄ¡
  • group-specific
    ±ºÆ¯ÀÌ-
  • group-specific antigen
    ¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
  • high risk group
    °íÀ§Ç豺
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • therapeutic ratio
    Ä¡·á°¡´Éºñ
  • therapeutic
    Ä¡·á-
  • therapeutic trial
    ½ÃÇèÀûÄ¡·á
  • ABO blood group system
    ¿¡À̺ñ¿ÀÇ÷¾×Çü±º
  • amino group
    ¾Æ¹Ì³ë±â
  • atomic group
    ¿øÀÚ´Ü
  • group antigen
    ±ºÇ׿ø
  • group audiometry
    Áý´Üû·Â°Ë»ç
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çü±º
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • borderline group
    °æ°è±º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lutheran blood group system
    ·çÅͶõ Ç÷¾×Çü±º
  • P blood group system
    PÇ÷¾×Çü±º
  • Rh blood group
    RhÇ÷¾×Çü.
  • Rh blood group
    Rh Ç÷¾×Çü
  • Rh blood group system
    Rh Ç÷¾×Çü±º
  • amino group
    ¾Æ¹Ì³ë±â(¡­Ðñ).
  • analytic group psychotherapy
    ºÐ¼®Àû Áý´Ü Á¤½ÅÄ¡·á
  • anterior sinus group
    ÀüºÎºñµ¿±º
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ).
  • green or yellow vegetable group
    ³ìȲ»öä¼Ò·ù.
  • group
    ±º
  • group I fiber
    Á¦¥°¤Çí·A(ð¯ìéÏØàéë«).
  • group I fiber
    Á¦¥°±º¼¶À¯(ð¯ìéÏØàéë«).
  • group II fiber
    Á¦¥±¤Çí·A.
  • group II fiber
    Á¦¥± ±º¼¶À¯(ÏØàéë«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • therapeutic curettage
    Ä¡·áÀû ¼ÒÆÄ(¼ú)(Ä¡¿äÀû¼ÒÆÄ¼ú).
  • therapeutic cytapheresis
    Ä¡·áÀû ¼¼Æ÷¼ººÐäÁý¼ú
  • therapeutic donor insemination
    Ä¡·áÀû Á¤ÀÚ °ø¿©, ºñ¹è¿ìÀÚ°£ Àΰø¼öÁ¤(= AIH)
  • therapeutic dose
    Ä¡·á(¿ë)·®.
  • therapeutic drug monitoring
    Ä¡·áÀû ¾àÁ¦°¨½Ã
  • therapeutic drug monitoring
    Ä¡·áÀû ¾à¹°³óµµ ¸ð´ÏÅ͸µ, Ä¡·áÀû ¾à¹°³óµµ ÃøÁ¤.
  • therapeutic endoscopy
    Ä¡·áÀû ³»½Ã°æ.
  • therapeutic environment
    Ä¡·áÀû ȯ°æ(~ü»ÌÑ).
  • therapeutic equivalence
    Ä¡·áÀû µ¿µî¼º.
  • therapeutic erthrocytapheresis
    Ä¡·áÀû ÀûÇ÷±¸¼ººÐäÁý¼ú
  • therapeutic gain factor, TGF
    Ä¡·áÀ̵æ°è¼ö
  • therapeutic hemapheresis
    Ä¡·áÀû Ç÷¾×ºÐ¹Ý¼ú
  • therapeutic index
    Ä¡·á Áö¼ö
  • therapeutic index
    Ä¡·áÁö¼ö
  • therapeutic index
    Ä¡·áÁö¼ö.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complementation group
    »óº¸±º(ßÓÜÍÏØ)
  • critical group
    ÀӰ豺(×üÍ£ÏØ)
  • diazo group
    µð¾ÆÁ¶ ±â(Ðñ)
  • diazonium group
    µð¾ÆÁ¶´½ ±â(Ðñ)
  • earthy group
    Å伺±â(÷ÏàõÐñ)
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
  • fatty acyl group
    Áö¹æ(ò·Û¸) ¾Æ½Ç±â(Ðñ)
  • fidelity group
    Á¤È®µµ ±â(ïáü¬ÓøÐñ)
  • formimino group
    Æ÷¸§À̹̳ë±â(Ðñ)
  • formyl group
    Æ÷¸£¹Ð±â(Ðñ)
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ)
  • functional group isomer
    ÀÛ¿ë±â(íÂéÄÐñ) À̼ºÃ¼(ì¶àõô÷)
  • glucosyl group
    ±Û·çÄڽDZâ(Ðñ)
  • glycoaldehyde group
    ±Û¶óÀÌÄھ˵¥ÇÏÀ̵å±â(Ðñ)
  • glycolaldehyde group
    ±Û¶óÀÌÄݾ˵¥ÇÏÀ̵å±â(Ðñ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
TR   1) Tricuspid Regurgitation
    = TI
  2) Therapeutic...
ASTRO American Society for Therapeutic Radiology and Oncology
CTRS certified therapeutic recreation specialist
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Group 4 group
Group A group 1
group B group A
Group D group
Group I group
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • borderline group
    °æ°è ±º
  • chloramphenicol group antibiotics
    Ŭ·Î¶÷Æä´ÏÄݱº Ç×»ýÁ¦
  • coxsackie group A virus
    ÄÛ»èŰ A±º ¹ÙÀÌ·¯½º
    ¼öÆ÷¼º º´º¯ÀÎ Æ÷Áø¼º ±¸Çù¿°À» ¹ß»ý ½ÃŲ´Ù.
  • Coxsackie virus group A
    A±º ÄÛ»çŰ ¹ÙÀÌ·¯½º
  • E-blood group
    ÀÌ½Ä Ç÷¾×Çü
    »ç¶÷ÀÇ Ç÷¾×ÇüÀÇ Çϳª. OÇü ÀÌ¿ÜÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ Áß¿¡¼­ ¹ìÀå¾îÀÇ Ç÷û ¼Ó¿¡ Á¸ÀçÇÏ´Â ÀÀÁý¼Ò¿¡ °­ÇÏ°Ô ¹ÝÀÀÇÏ´Â °ÍÀ» EÇü, ¹ÝÀÀÀÌ ¾àÇÑ °ÍÀ» eÇüÀ¸·Î ÇÏ´Â Ç÷¾×ÇüÀ» ¸»ÇÑ´Ù. EÇüÀº ABO½ÄÀÇ BÇü¿¡ °¡Àå ¸¹°í, A, AB ¼øÀ¸·Î ºóµµ°¡ ³·´Ù. ¶ÇÇÑ À¯ÀüÀÚÇü°úµµ °ü°è°¡ ÀÖÀ¸¸ç II, II
  • herpes group of virus
    Æ÷Áø¼º ¹ÙÀÌ·¯½º
  • high risk group
    °íÀ§Çèµµ±º
  • Lutheran blood group
    ·çÅ×¶õ½Ä Ç÷¾×Çü
    Ç÷¾×ÇüÀÇ ÀÏÁ¾. ¿ì¿­ÀÌ ¾ø´Â ÇÑ ½ÖÀÇ ´ë¸³ À¯ÀüÀÚ Lu, Lu¿¡ ÀÇÇØ¼­ Áö¹èµÇ°í, ÀÌ À¯ÀüÀÚÀÇ Á¶ÇÕ¿¡ µû¶ó¼­ »ç¶÷ÀÇ Ç÷±¸´Â Lu
  • methyl green-pyronin of nucleolus

    methyl group

    ¸ÞÄ¥±â
  • myelinated group
    À¯¼öÃʱº
  • open group
    °ø°³ Áý´Ü
  • posterior group nuclei
    ÈĺΠÇÙ
  • posterior nuclear group
    ÈÄÇÙ Áý´Ü
  • prosthetic group
    ¹èÇÕ±º
  • Q : Àü±â·®ÀÇ coulombÀÇ ±âÈ£.

    Q blood group system

    Å¥½Ä Ç÷¾×Çü
    Ç÷¾×ÇüÀÇ Çϳª. µÅÁö Ç÷ûÀÇ ¾î¶² °Í¿¡ Á¸ÀçÇÏ´Â Ç× Q ÀÀÁý¼Ò¸¦ °¡ÇßÀ» ¶§ ÀÀÁýÇϴ°¡ ÇÏÁö ¾Ê´Â°¡¿¡ µû¶ó Ç÷¾×À» ºÐ·ùÇÏ´Â °ÍÀÌ´Ù. Ç× QÀÀÁý¼Ò´Â P½Ä Ç÷¾×ÇüÀÇ Ç× P ÀÀÁý¼Ò¿Í µ¿ÀÏÇÑ °ÍÀ̶ó´Â Çм³µµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
therapeutic malaria Intentionally induced malaria, formerly used against neurosyphilis and certain other paralytic diseases; the mechanism is thought to be immunological, with Plasmodium antibodies cross-reacting against the spirochetes or other agents.
(05 Mar 2000)
therapeutic pessimism A disbelief in the curative virtues of remedies in general and especially of drugs.
(05 Mar 2000)
therapeutic pneumothorax Pneumothorax designed to create some pulmonary parenchymal collapse, diaphragmatic immobilization, or both.
(05 Mar 2000)
therapeutic ratio The ratio of the maximally tolerated dose of a drug to the minimal curative or effective dose; LD50 divided by ED50.
(05 Mar 2000)
therapeutic touch The placing of the hands of the healer upon the person to be cured.
(12 Dec 1998)
therapeutic vaccine An injected therapy consisting of synthetic HIV antigen (for example, gp160) that is administered to people who already have HIV It is supposed to heighten and broaden the immune response to HIV, helping to halt disease progression.
(09 Oct 1997)
embolization, therapeutic A method of haemostasis utilizing various agents such as gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and cerebral arteriovenous malformations, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumours, traumatic rupture of blood vessels, and control of operative haemorrhage.
(12 Dec 1998)
ABO blood group <haematology> The major human blood type system which describes the oligosaccharide glycoprotein antigens found on the surface of human blood cells.
According to the type of antigen present, a person may be assigned a blood type of A, B, AB or O. A second type of antigen, the Rh factor, renders a positive or negative blood type. The ABO blood group system is important because it determines who can donate blood to or accept blood from whom.
Type A or AB blood will cause an immune reaction in people with type B blood and type B and AB blood will cause a reaction in people with type A blood.
Conversely, type O blood has no A or B antigens, so people with type O blood are universal donors.
And since AB blood already produces both antigens, people who are type AB can accept any of the other blood types without suffering an immune reaction.
(04 Jul 1999)
actinobacteria group A group of gram-positive, heterogeneous bacteria. This group encompasses a range of morphologically, physiologically, and chemically different organisms and includes bacteria that form cocci, short rods, irregular rods, and mycelia that fragment.
(12 Dec 1998)
alkyl group <chemistry> A funtional group on an organic molecule which is derived from an alkane which has lost a hydrogen atom.
(13 Nov 1997)
aluminum group Aluminum, boron, gallium, indium, and thallium.
(05 Mar 2000)
amino group <biochemistry> An -NH2 group. Organic compounds which have this group are called amines.
(09 Oct 1997)
anterior group of axillary lymph nodes Lymph nodes located along the lateral thoracic vein; they receive the drainage of the pectoral region, including most of the drainage of the breast.
Synonym: nodi lymphatici axillaris pectorales, anterior group of axillary lymph nodes.
(05 Mar 2000)
apical group of axillary lymph nodes The group of lymph node's located at the apex of the axillary fossa that receive lymphatic drainage from other groups of axillary node's and then drain in turn into the subclavian lymphatic trunk.
Synonym: nodi lymphatici axillares apicales.
(05 Mar 2000)
Bethesda-Ballerup Group A group of citrate-utilizing, slow lactose-fermenting bacteria (family Enterobacteriaceae) which share a similar series of antigens with the lactose-fermenting citrobacters; these organisms are now included in the genus Citrobacter without a distinction between prompt and slow lactose fermentation.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ginger group
    (Á¤´ç µûÀ§ Á¶Á÷ ³»ºÎÀÇ)Çõ½ÅÆÄ
  • group
    ¹«¸®;ºñÇà ´ë´ë;ºñÇà ¿¬´ë
  • group
    ¸ðÀ¸(ÀÌ)´Ù;ºÐ·ùÇÏ´Ù
  • group captain
    °ø±º ´ë·É
  • group dynamics
    Áý´Ü ¿ªÇÐ
  • group grope
    È¥À½ ÆÄƼ;Áý´Ü Á¢ÃË
  • group insurance
    ´Üü º¸Çè
  • group marriage
    (¹Ì°³ ÀÎÁ¾ÀÇ) Áý´Ü °áÈ¥;ÀâÈ¥
  • group medicine
    =GROUP PRACTICE
  • group mind
    ±ºÁß ½É¸®
  • group practice
    (¿©·¯ Àü¹®ÀÇÀÇ)Áý´Ü ÀÇ·á;(¿©·¯ ȯÀÚ¿¡ ´ëÇÑ)Áý´Ü °ËÁø ,
  • group psychology
    ±ºÁß ½É¸®ÇÐ
  • group sex
    Áý´Ü ¼º±³
  • group theory
    ±º·Ð
  • group therapy
    Áý´Ü ¿ä¹ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á